scholarly article | Q13442814 |
P50 | author | Sholom Wacholder | Q28360636 |
Nicolas Wentzensen | Q28360639 | ||
Robert D Burk | Q56916578 | ||
Arpita Ghosh | Q58840188 | ||
Mark Schiffman | Q69142146 | ||
Rolando Herrero | Q91231612 | ||
Lisa Mirabello | Q114374098 | ||
Allan Hildesheim | Q37241774 | ||
Ana Cecilia Rodríguez | Q37242392 | ||
P2093 | author name string | Chang Sun | |
Attila Lorincz | |||
P2860 | cites work | Global cancer statistics | Q22241238 |
Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry | Q24536837 | ||
Strategies and mechanisms for host and pathogen survival in acute and persistent viral infections | Q24563791 | ||
Methylation of HPV16 genome CpG sites is associated with cervix precancer and cancer | Q24633086 | ||
Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms | Q24811510 | ||
Pyrosequencing sheds light on DNA sequencing | Q28142599 | ||
The papillomavirus life cycle | Q28238578 | ||
Natural history of cervicovaginal papillomavirus infection in young women. | Q50909200 | ||
The carcinogenicity of human papillomavirus types reflects viral evolution. | Q53357731 | ||
Human papillomavirus and cervical cancer | Q54023273 | ||
Analysis of gene-specific DNA methylation patterns by pyrosequencing technology. | Q54565743 | ||
The fate of foreign DNA in mammalian cells and organisms | Q64379384 | ||
Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste Project | Q73407381 | ||
Heterogeneity in CIN3 diagnosis | Q81204249 | ||
DNA methylation analysis by pyrosequencing | Q81247006 | ||
Accepting the universal truths of cervical human papillomavirus epidemiology in pursuit of the remaining mysteries | Q84968349 | ||
MethPrimer: designing primers for methylation PCRs | Q29618664 | ||
Using biomarkers as objective standards in the diagnosis of cervical biopsies | Q30431203 | ||
Laser capture microdissection of cervical human papillomavirus infections: copy number of the virus in cancerous and normal tissue and heterogeneous DNA methylation | Q33460823 | ||
Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection | Q33698774 | ||
Temporal usage of multiple promoters during the life cycle of human papillomavirus type 31b. | Q33783002 | ||
Distinct human papillomavirus type 16 methylomes in cervical cells at different stages of premalignancy | Q34052412 | ||
A higher degree of methylation of the HPV 16 E6 gene is associated with a lower likelihood of being diagnosed with cervical intraepithelial neoplasia | Q34504577 | ||
CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression | Q34996306 | ||
Stealth technology: how Epstein-Barr virus utilizes DNA methylation to cloak itself from immune detection. | Q35571278 | ||
Viral oncoproteins target the DNA methyltransferases | Q35954845 | ||
High-throughput detection of human papillomavirus-18 L1 gene methylation, a candidate biomarker for the progression of cervical neoplasia | Q35989077 | ||
Molecular biology of human papillomavirus infection and cervical cancer | Q36441612 | ||
Functional analysis of the human papillomavirus type 16 E1=E4 protein provides a mechanism for in vivo and in vitro keratin filament reorganization. | Q36944507 | ||
Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections | Q36994715 | ||
Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study | Q37137085 | ||
The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer | Q37142007 | ||
In pursuit of the first recognized epigenetic signal--DNA methylation: a 1976 to 2008 synopsis | Q37167157 | ||
Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study | Q37281729 | ||
Transcriptional regulation of the papillomavirus oncogenes by cellular and viral transcription factors in cervical carcinoma | Q37343877 | ||
Human papillomavirus-16 and -18 in penile carcinomas: DNA methylation, chromosomal recombination and genomic variation | Q37361262 | ||
Pathway analysis by adaptive combination of P-values | Q37464310 | ||
Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia | Q37596549 | ||
Viral epigenomes in human tumorigenesis. | Q37681282 | ||
Methylation of the long control region of HPV16 is related to the severity of cervical neoplasia | Q39789073 | ||
Epstein-Barr virus and gastric carcinoma--viral carcinogenesis through epigenetic mechanisms. | Q40048502 | ||
Clonal selection for transcriptionally active viral oncogenes during progression to cancer. | Q40163392 | ||
Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. | Q40227526 | ||
Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica,. | Q40523867 | ||
Recombination of human papillomavirus-16 and host DNA in exfoliated cervical cells: a pilot study of L1 gene methylation and chromosomal integration as biomarkers of carcinogenic progression | Q43781423 | ||
CpG methylation of HPV 16 LCR at E2 binding site proximal to P97 is associated with cervical cancer in presence of intact E2. | Q43785734 | ||
Methylation of the human papillomavirus-18 L1 gene: a biomarker of neoplastic progression? | Q46041240 | ||
Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication | Q47860026 | ||
Prediction of human papillomavirus 16 e6 gene expression and cervical intraepithelial neoplasia progression by methylation status | Q47903873 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 556-565 | |
P577 | publication date | 2012-03-23 | |
P1433 | published in | Journal of the National Cancer Institute | Q400279 |
P1476 | title | Methylation of human papillomavirus type 16 genome and risk of cervical precancer in a Costa Rican population | |
P478 | volume | 104 |
Q37671558 | A comparison of methylation levels in HPV18, HPV31 and HPV33 genomes reveals similar associations with cervical precancers |
Q36254941 | A joint model of persistent human papillomavirus infection and cervical cancer risk: Implications for cervical cancer screening |
Q35125113 | A promising DNA methylation signature for the triage of high-risk human papillomavirus DNA-positive women |
Q40299423 | Approaches for triaging women who test positive for human papillomavirus in cervical cancer screening |
Q52631128 | Assessment of viral methylation levels for high risk HPV types by newly designed consensus primers PCR and pyrosequencing. |
Q44863515 | Carcinogenic human papillomavirus infection |
Q33703182 | Characterization of HPV DNA methylation of contiguous CpG sites by bisulfite treatment and massively parallel sequencing-the FRAGMENT approach. |
Q36104985 | CpG Methylation Analysis of HPV16 in Laser Capture Microdissected Archival Tissue and Whole Tissue Sections from High Grade Anal Squamous Intraepithelial Lesions: A Potential Disease Biomarker |
Q38912763 | DNA methylation at hepatitis B viral integrants is associated with methylation at flanking human genomic sequences |
Q30685686 | Deep sequencing of HPV16 genomes: A new high-throughput tool for exploring the carcinogenicity and natural history of HPV16 infection |
Q36385102 | Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia |
Q92528818 | Epigenetic regulation of human papillomavirus transcription in the productive virus life cycle |
Q30239987 | Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice |
Q48110805 | Evaluation of p16/Ki-67 dual-stained cytology as triage test for high-risk human papillomavirus-positive women. |
Q28076194 | Evasion of host immune defenses by human papillomavirus |
Q36459298 | Folate and vitamin B12 may play a critical role in lowering the HPV 16 methylation-associated risk of developing higher grades of CIN. |
Q97527612 | Genome-wide identification of methylated CpG sites in nongenital cutaneous warts |
Q33735179 | Genotype-specific methylation of HPV in cervical intraepithelial neoplasia. |
Q53176137 | HPV DNA methylation at the early promoter and E1/E2 integrity: A comparison between HPV16, HPV18 and HPV45 in cervical cancer. |
Q36856284 | HPV-based Tests for Cervical Cancer Screening and Management of Cervical Disease |
Q36901882 | HPV16 CpG methyl-haplotypes are associated with cervix precancer and cancer in the Guanacaste natural history study |
Q37001814 | HPV16 L1 and L2 DNA methylation predicts high-grade cervical intraepithelial neoplasia in women with mildly abnormal cervical cytology |
Q34675069 | HPV16 methyl-haplotypes determined by a novel next-generation sequencing method are associated with cervical precancer |
Q33740118 | Human Papillomavirus 16, 18, 31 and 45 viral load, integration and methylation status stratified by cervical disease stage. |
Q50115891 | Human Papillomavirus DNA methylation as a biomarker for cervical precancer: Consistency across 12 genotypes and potential impact on management of HPV-positive women |
Q36876059 | Human papillomavirus DNA methylation as a potential biomarker for cervical cancer |
Q26995703 | Human papillomavirus and cancer prevention: gaps in knowledge and prospects for research, policy, and advocacy |
Q35604116 | Human papillomavirus genomics: past, present and future |
Q37013482 | Human papillomavirus infection and the multistage carcinogenesis of cervical cancer |
Q36311573 | Laboratory and clinical aspects of human papillomavirus testing |
Q59353450 | Methylation in host and viral genes as marker of aggressiveness in cervical lesions: Analysis in 543 unscreened women |
Q92125816 | Methylation of CpG 5962 in L1 of the human papillomavirus 16 genome as a potential predictive marker for viral persistence: A prospective large cohort study using cervical swab samples |
Q36606686 | Methylation of HPV18, HPV31, and HPV45 genomes and cervical intraepithelial neoplasia grade 3. |
Q91596225 | Methylation of High-Risk Human Papillomavirus Genomes Are Associated with Cervical Precancer in HIV-Positive Women |
Q33733302 | Methylation of human papillomavirus 16, 18, 31, and 45 L2 and L1 genes and the cellular DAPK gene: Considerations for use as biomarkers of the progression of cervical neoplasia |
Q54231184 | Molecular progression to cervical precancer, epigenetic switch or sequential model? |
Q26851699 | New strategies for human papillomavirus-based cervical screening |
Q38064058 | New technologies and procedures for cervical cancer screening |
Q36589155 | Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling |
Q90731036 | Performance of DNA methylation assays for detection of high-grade cervical intraepithelial neoplasia (CIN2+): a systematic review and meta-analysis |
Q33742722 | Prognostic significance of LINE-1 hypomethylation in oropharyngeal squamous cell carcinoma. |
Q38597567 | Prophylactic HPV vaccination: past, present, and future |
Q40341777 | Quantitative Measurement of L1 Human Papillomavirus Type 16 Methylation for the Prediction of Preinvasive and Invasive Cervical Disease |
Q43924111 | Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Clinical Practice Guideline |
Q38168923 | The current position and the future perspectives of cervical cancer screening |
Q58738110 | The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications |
Q36679896 | Triage of HPV positive women in cervical cancer screening |
Q38824019 | Triage of high-risk HPV positive women in cervical cancer screening. |
Q36799858 | Validation of a DNA methylation HPV triage classifier in a screening sample |
Q42245758 | Viral and cellular biomarkers in the diagnosis of cervical intraepithelial neoplasia and cancer |
Q89422224 | [Epidemiology, prevention and early detection of cervical cancer] |